TYRA Tyra Biosciences, Inc.
$20.43
Tyra Biosciences, Inc. (TYRA) Earnings News
Earnings press releases, previews and reviews for Tyra Biosciences, Inc. (TYRA), newest first.
Friday
September 4, 2026
8:00 AM ET
Tyra Biosciences to Host Conference Call on Initial Results of Oral Dabogratinib from the SURF302 Phase 2 Study for IR NMIBC on September 9, 2026
Tuesday
August 4, 2026
4:05 PM ET
Tyra Biosciences Reports Second Quarter 2026 Financial Results and Recent Highlights
Wednesday
May 13, 2026
8:00 AM ET
Tyra Biosciences Reports First Quarter 2026 Financial Results and Recent Highlights